June 18-20, 2017
GlaxoSmithKline, Tres Cantos, Madrid, Spain
The second edition of the meeting, organized by the Society for Chemical Industry’s Fine Chemicals Group, will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts, alongside perspectives detailing case histories in drug discovery.
Ben Perry, NTD Drug Discovery Booster Project Manager and Charles Mowbray, Head of Discovery, DNDi, presented on the NTD Discovery Booster, aminopyrazoles and NTDs.